Skip to main content

Peabody Treatment Progress Battery

By

Peabody Treatment Progress Battery

(PTPB); Bickman et al., 2010)

The Peabody Treatment Progress Battery (PTPB) is a set of 11 measures designed to assess mental health outcomes and clinical processes in youth ages 11-18. The information is collected from youth, caregivers, and clinicians, and the measures are appropriate for use as screening tools and for monitoring symptom changes over time (Riemer et al., 2012). The PTPB is intended for use in service settings such as individual outpatient, foster care, and in-home treatment (Bickman et al., 2010). The measures within the PTPB are brief, ranging from 2 to 26 items, and can be administered in just five to eight minutes (Bickman et al., 2010). The first six measures focus on treatment outcomes, while the latter five measures focus on treatment processes such as therapeutic alliance and treatment expectation (Riemer et al., 2012). The first six measures are also sensitive to symptom changes due to treatment (Riemer et al., 2012).

Component Description
Peabody Treatment Progress Battery (PTPB) A set of 11 measures assessing mental health outcomes and clinical processes for youths ages 11-18
Information collected From youth, caregivers, and clinicians
Purpose To be used as screening tools and to monitor symptom changes over time
Intended use In service settings such as individual outpatient, foster care, and in-home treatment
Measure length 2 to 26 items, brief and can be administered in five to eight minutes
First six measures Focus on treatment outcomes
Last five measures Focus on treatment processes (e.g., therapeutic alliance, treatment expectation)
Sensitivity First six measures are sensitive to symptom change as a result of treatment

References:
Bickman, L., Foster, E. M., Szalacha, L. A., Lambert, E. W., & Lehman, A. J. (2010). The Peabody Treatment Progress Battery: Development, psychometric properties, and utility. Journal of Consulting and Clinical Psychology, 78(3), 309-319.
Riemer, M., Bickman, L., & Foster, E. M. (2012). Use of the Peabody Treatment Progress Battery with youth in outpatient mental health treatment. Psychological Assessment, 24(2), 496-505.
Labels:
Location: Yorkshire, UK

Comments

Post a Comment

Your Thoughts?

Popular posts from this blog

ADVOKATE: A Mnemonic Tool for the Assessment of Eyewitness Evidence

By
ADVOKATE: A Mnemonic Tool for Assessment of Eyewitness Evidence A tool for assessing eyewitness  ADVOKATE is a tool designed to assess eyewitness evidence and how much it is reliable. It requires the user to respond to several statements/questions. Forensic psychologists, police or investigative officer can do it. The mnemonic ADVOKATE stands for: A = amount of time under observation (event and act) D = distance from suspect V = visibility (night-day, lighting) O = obstruction to the view of the witness K = known or seen before when and where (suspect) A = any special reason for remembering the subject T = time-lapse (how long has it been since witness saw suspect) E = error or material discrepancy between the description given first or any subsequent accounts by a witness.  Working with suspects (college.police.uk)
Post a Comment
Read more

ICD-11 Criteria for Attention Deficit Hyperactivity Disorder (ADHD) 6A05

By
ICD-11 Criteria for Attention Deficit Hyperactivity Disorder (ADHD) 6A05 Attention deficit hyperactivity disorder is characterised by a persistent pattern (at least 6 months) of inattention and/or hyperactivity-impulsivity that has a direct negative impact on academic, occupational, or social functioning. There is evidence of significant inattention and/or hyperactivity-impulsivity symptoms prior to age 12, typically by early to mid-childhood, though some individuals may first come to clinical attention later. The degree of inattention and hyperactivity-impulsivity is outside the limits of normal variation expected for age and level of intellectual functioning. Inattention refers to significant difficulty in sustaining attention to tasks that do not provide a high level of stimulation or frequent rewards, distractibility and problems with organisation. Hyperactivity refers to excessive motor activity and difficulties with remaining still, most evident in structured situations that re...
Post a Comment
Read more

ICD-11 Criteria for Anorexia Nervosa (6B80)

By
ICD-11 Criteria for Anorexia Nervosa (6B80) Anorexia Nervosa is characterised by significantly low body weight for the individual’s height, age and developmental stage that is not due to another health condition or to the unavailability of food. A commonly used threshold is body mass index (BMI) less than 18.5 kg/m2 in adults and BMI-for-age under 5th percentile in children and adolescents. Rapid weight loss (e.g. more than 20% of total body weight within 6 months) may replace the low body weight guideline as long as other diagnostic requirements are met. Children and adolescents may exhibit failure to gain weight as expected based on the individual developmental trajectory rather than weight loss. Low body weight is accompanied by a persistent pattern of behaviours to prevent restoration of normal weight, which may include behaviours aimed at reducing energy intake (restricted eating), purging behaviours (e.g. self-induced vomiting, misuse of laxatives), and behaviours aimed at incr...
Post a Comment
Read more